The inhibitory action of BOF-A2, a 5-fluorouracil derivative, on squamous cell carcinoma

Cancer Letters

Volumn 137, Issue 1, 1999, Pages 17-25

  Yoneda, Kazunori ^a   Yamamoto, Tetsuya ^a   Ueta, Eisaku ^a   Osaki, Tokio ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

5 Fluorouracil; Antitumor activity; Apoptosis; BOF A2; Squamous cell carcinoma

Indexed keywords

DNA FRAGMENT; EMITEFUR; FLUOROURACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; DNA SYNTHESIS INHIBITION; DRUG RESISTANCE; HISTOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FLUOROURACIL; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0032926767     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00330-9     Document Type: Article

References (40)

1. Sakaguchi Y., Stephens L.C., Makino M., et al. Apoptosis in normal tissues induced by 5-fluorouracil: Comparison between bolus injection and prolonged infusion. Anticancer Res. 14:1994;1489-1492.
2. Pickard M., Dive C., Kinsella A.R. Differences in resistance to 5-fluorouracil as a function of cell cycle delay and not apoptosis. Br. J. Cancer. 72:1995;1389-1396.
3. Sugamura K., Makino M., Shirai H., et al. Enhanced induction of apoptosis of human gastric carcinoma cells after preoperative treatment with 5-fluorouracil. Cancer. 79:1997;12-17.
4. Ueda M., Kumagai K., Ueki K., et al. Growth inhibition and apoptotic cell death in uterine cervical carcinoma cells induced by 5-fluorouracil. Int. J. Cancer. 71:1997;668-674.
5. Inada T., Ichikawa A., Kubota T., et al. 5-FU-induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice. Anticancer Res. 17:1997;1965-1972.
6. Frizson P. The relation between uracil catabolizing enzymes and rate of rat liver regeneration. J. Biol. Chem. 237:1962;150-156.
7. Oueener S.F., Morris H.P., Weber G. Dihydrouracil dehydrogenase activity in normal, differentiating and regenerating liver and hepatomas. Cancer Res. 31:1971;1004-1009.
8. Fujii S., Fukushima M., Shimamoto Y., et al. Antitumor activity of BOF-A2, a new 5-fluorouracil derivative. Jpn. J. Cancer Res. 80:1989;173-181.
9. Tatsumi K., Fukushima M., Shirasaka T., et al. Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts. Jpn. J. Cancer Res. 78:1987;748-755.
10. Shirasaka T., Fujita F., Fujita M., et al. Antitumor activity and metabolism of BOF-A2, a new 5-fluorouracil derivative, with human cancers xenografted in nude mice. Jpn. J. Cancer Chemother. 17:1990;1871-1876.
11. Osaki T., Tatemoto Y., Yoneda K., et al. Tumorigenicity of cell lines established from oral squamous cell carcinoma and its metastatic lymph nodes. Oral Oncol. Eur. J. Cancer. 30B:1994;296-301.
12. Yoneda K., Yokoyama T., Yamamoto T., et al. p53 gene mutations and p21 protein expression induced by TGF-β and γ-rays in squamous cell carcinoma cells: No involvement of p53 in the induction. Eur. J. Cancer. 1998;. in press.
13. Toide H., Akiyoshi H., Minato Y. Comparative studies on the metabolism of 2-(tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil. Gann. 68:1977;553-560.
14. Kono A., Hara Y., Matsushima Y. Enzymatic formation of 5-fluorouracil from 1-(tetrahydro-2-furanyl)-5-fluorouracil (tegafur) in human tumor tissues. Chem. Pharm. Bull. 29:1981;1486-1488.
15. Pazdur R., Lassere Y., Diaz-Canton E., et al. Phase trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule. Cancer Invest. 16:1998;145-151.
16. Ikenaka K., Shirasaka T., Kitano S., et al. Effect of uracil on metabolism of 5-fluorouracil in vitro. Gann. 70:1979;353-359.
17. Rai S.S., Wolff J. The C terminus of beta-tubulin regulates vinblastine- induced tubulin polymerization. Proc. Natl. Acad. Sci. USA. 95:1998;4253-4257.
18. Ross W., Rowe T., Glisson B., et al. Role of topoisomerase in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res. 44:1984;5857-5860.
19. Cotter T.G., Glynn J.M., Echeverri F., et al. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res. 12:1992;773-780.
20. Inaba M., Mitsuhashi J. Flow cytometric analysis of cell-killing actions of 5- fluorouracil in human colorectal cancer cells. Oncol. Res. 6:1994;303-309.
21. Parker W.B., Cheng Y.C. Metabolism and mechanism of action of 5- fluorouracil. Pharmacol. Ther. 48:1990;381-395.
22. Mathews M.B., Bernstein R.M., Franza B.R. Jr. Identity of the proliferating cell nuclear antigen and cyclin. Nature. 309:1984;374-376.
23. Miyachi K., Fritzler M.J., Tan E.M. Autoantibody to a nuclear antigen in proliferating cells. J. Immunol. 121:1978;2228-2234.
24. Tsurimoto T., Melendy T., Stillman B. Sequential initiation of lagging and leading strand synthesis by two different polymerase complexes at the SV40 DNA replication origin. Nature. 346:1990;534-539.
25. Waga S., Stillman B. Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication in vitro. Nature. 369:1994;207-212.
26. Okamoto S., Sakai M., Uchida J., et al. 5-Fluorouracil induces apoptotic cell death with G2 phase arrest in human breast cancer grafted in nude mice. Anticancer Res. 16:1996;2699-2704.
27. Shinomiya N., Takemura T., Iwamoto K., et al. Caffeine induces S-phase apoptosis in cis-diamminedichloroplatinum-treated cells, whereas cis- diamminedichloroplatinum induces a block in G2/M. Cytometry. 27:1997;365-373.
28. Pritchard D.M., Watson A.J.M., Potten C.S., et al. Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5- fluorouracil: evidence for the involvement of RNA perturbation. Proc. Natl. Acad. Sci. USA. 94:1997;1795-1799.
29. Koshiji K., Adachi Y., Taketani S., et al. Mechanisms underlying apoptosis induced by combination of 5-fluorouracil and interferon-γ Biochem. Biophys. Res. Commun. 240:1997;376-381.
30. Yoneda K., Yamamoto T., Osaki T. p53- and p21-independent apoptosis of squamous cell carcinoma cells induced by 5-fluorouracil and radiation. Oral Oncol. 1998;. in press.
31. Poumay Y., Pittelkow M.R. Cell density and culture factors regulate keratinocyte commitment to differentiation and expression of suprabasal K1/K10 keratins. J. Invest. Dermatol. 104:1995;271-276.
32. Ming M.E., Daryanani H.A., Roberts L.P., et al. Binding of keratin intermediate filaments (K10) to the cornified envelope in mouse epidermis: implications for barrier function. J. Invest. Dermatol. 103:1994;780-784.
33. Warhol M.J., Roth J., Lucocq J.M., et al. Immuno-ultrastructural localization of involucrin in squamous epithelium and cultured keratinocytes. J. Histochem. Cytochem. 33:1985;141-149.
34. Gibson D.F.C., Ratnam A.V., Bikle D.D. Evidence for separate control mechanisms at the message, protein, and enzyme activation levels for transglutaminase during calcium-induced differentiation of normal and transformed human keratinocytes. J. Invest. Dermatol. 106:1996;154-161.
35. Jetten A.M., George M.A., Pettit G.R., et al. Action of phorbol esters, bryostatins, and retinoic acid on cholesterol sulfate synthesis: relation to the multistep process of differentiation in human epidermal keratinocytes. J. Invest. Dermatol. 93:1989;108-115.
36. Osada S., Mizuno K., Saido T.C., et al. A phorbol ester receptor/protein kinase, nPKCη, a new member of the protein kinase C family predominantly expressed in lung and skin. J. Biol. Chem. 265:1990;22434-22440.
37. Denning M.F., Kazanietz M.G., Blumberg P.M., et al. Cholesterol sulfate activates multiple protein kinase C isoenzymes and induces granular cell differentiation in cultured murine keratinocytes. Cell Growth Differ. 6:1995;1619-1626.
38. Ravi R., Bedi A., Fuchs E.J., et al. CD95(Fas)-induced caspase-mediated proteolysis of NF-kappa B. Cancer Res. 58:1998;882-886.
39. Enari M., Sakahira H., Yokoyama H., et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
40. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.